Invivyd to Host Conference Call Discussing Second Quarter 2023 Financial Results and Business Highlights
Rhea-AI Summary
Invivyd, Inc. (IVVD) to Host Conference Call to Discuss Q2 2023 Financial Results and Business Highlights
08/03/2023 - 04:01 PM
WALTHAM, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced that it will host a conference call on Thursday, August 10, 2023, at 4:30 p.m. ET to discuss its financial results for the quarter ended June 30, 2023, and recent business highlights.
Listeners can register for the webcast via this link . Analysts wishing to participate in the question and answer session should use this link . A replay of the webcast will be available in the investor section of the company’s website approximately two hours after the end of the call. Those who plan on participating are advised to join 15 minutes prior to the start time.
About Invivyd Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company on a mission to rapidly and perpetually deliver antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, beginning with SARS-CoV-2. Invivyd’s technology works at the intersection of evolutionary virology, predictive modeling, and antibody engineering, and is designed to identify high-quality, long-lasting antibodies with the potential to resist viral escape. The company is generating a robust pipeline of product candidates which could be used in prevention or treatment of serious viral diseases, starting with COVID-19 and expanding into influenza and other high-need indications. Visit https://invivyd.com/ to learn more.
Media Contact: Kate Burdick, Evoke Canale 860-462-1569kate.burdick@evokegroup.com
Investor Contact: Chris Brinzey, ICR Westwicke 339-970-2843chris.brinzey@westwicke.com
What is the date of Invivyd, Inc.'s conference call to discuss its financial results for the quarter ended June 30, 2023?
Invivyd, Inc. will host a conference call on Thursday, August 10, 2023, at 4:30 p.m. ET to discuss its financial results for the quarter ended June 30, 2023, and recent business highlights.
How can listeners register for the webcast of the conference call?
Listeners can register for the webcast via the provided link in the press release.
When will the replay of the webcast be available?
A replay of the webcast will be available in the investor section of the company’s website approximately two hours after the end of the call.
IVVD Rankings
#4901 Ranked by Stock Gains
IVVD Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
About IVVD
adagio is developing best-in-class antibodies that can broadly neutralize sars-cov-2, sars-cov-1 and additional potentially emergent coronaviruses. we believe our antibodies will match or exceed the potency and coverage of conventional sars-cov-2 antibody programs and can be used as both therapeutic and durable prophylactic treatments. our candidates are engineered using best-in-industry antibody discovery capabilities and are designed to maximize potency and duration of effect. our portfolio includes multiple, non-competing antibodies with distinct binding targets, enabling a strategy that can avoid viral escape. our lead program is expected to enter the clinic by the end of 2020.